XM does not provide services to residents of the United States of America.
E
E

Ecolab

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

U.S. Airbnb, Post Holdings, Syndax Pharmaceuticals

U.S. RESEARCH ROUNDUP- Airbnb, Post Holdings, Syndax Pharmaceuticals Nov 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Airbnb, Post Holdings and Syndax Pharmaceuticals, on Monday. HIGHLIGHTS * Airbnb Inc ABNB.O : D.A. Davidson raises PT to $131 from $125 * Korro Bio Inc KRRO.O : Jonestrading initiates coverage with buy rating; PT $130 * Post Holdings Inc POST.N : JP Morgan raises target price to $135 from $125 *
A
A
B
E
G
H
S
D
D
E
E
A
C
C
D
I

Ecolab Acquires Barclay Water Management

BRIEF-Ecolab Acquires Barclay Water Management Nov 5 (Reuters) - Ecolab Inc ECL.N : ECOLAB ACQUIRES BARCLAY WATER MANAGEMENT ECOLAB INC: ADDITIONAL TRANSACTION TERMS WILL BE DISCLOSED Source text: ID:nBw7dML5qa Further company coverage: ECL.N ( Reuters.Briefs@thomsonreuters.com )
E

Ecolab Acquires Barclay Water Management

BRIEF-Ecolab Acquires Barclay Water Management Nov 5 (Reuters) - Ecolab Inc ECL.N : ECOLAB INC: ADDITIONAL TRANSACTION TERMS WILL NOT BE DISCLOSED ECOLAB ACQUIRES BARCLAY WATER MANAGEMENT Source text: [ID:] Further company coverage: ECL.N
E

U.S. Altair Engineering, Brinker International, Meta

U.S. RESEARCH ROUNDUP-Altair Engineering, Brinker International, Meta Oct 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Altair Engineering, Brinker International and Meta, on Thursday. HIGHLIGHTS * Altair Engineering Inc ALTR.O : Needham cuts to hold from buy * Blackbaud Inc BLKB.O : Baird cuts to neutral from outperform * Brinker International Inc EAT.N : JP Morgan cuts to neutral from overweight * Comstock Res
A
A
B
B
C
C
E
G
I
M
S
V
V
A
A
C
K
E
C

U.S. Agilon Health, Alphabet, Crocs

U.S. RESEARCH ROUNDUP-Agilon Health, Alphabet, Crocs Oct 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Agilon Health, Alphabet and Crocs, on Wednesday. HIGHLIGHTS * Agilon Health Inc AGL.N : Citigroup cuts to sell from neutral * Alphabet Inc GOOGL.O : Seaport Research Partners raises to buy from neutral * Crocs Inc CROX.O : Raymond James cuts to market perform from outperform * Leggett & Platt Inc LEG.N : Piper
A
B
C
G
I
M
Q
V
V
A
E
E
S
U
A
A
F
L
R

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.